Patents by Inventor Audrey Ferrand

Audrey Ferrand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICROPHYSIOLOGICAL SYSTEM AND USES THEREOF
    Publication number: 20250283020
    Abstract: The invention relates to a microfluidic device (1) comprising a frame (32) and two opposite walls (16a,b), the two opposite walls (16a,b) and the frame (32) delimiting together a chamber (2): —the chamber (2) comprising a first zone (4) and a second zone (5), —the second zone (5) comprising a porous member (3) extending in the chamber (2) and comprising a first surface (9) and a second surface (10) opposite to the first surface (9), the first surface (9) separating the chamber (2) in the first zone (4) and in the second zone (5), —the frame (32) comprising at least a first and a second sets of ports (11, 12, 13, 14), the first set of port comprising at least two ports (11, 12) arranged in the frame (32) for fluid circulation within in the first zone (4) and the second set of ports comprising at least two ports (13, 14) arranged in the frame (32) for fluid circulation within the second zone (5), and—the two ports (13, 14) of the second set of ports being open (i) in a microchannel (15) extending through the po
    Type: Application
    Filed: December 7, 2022
    Publication date: September 11, 2025
    Inventors: Dimitri HAMEL, Audrey FERRAND, Julie FONCY, Laurent MALAQUIN
  • Method for predicting the risk of developing a colonic neoplasia
    Patent number: 9410955
    Abstract: The present invention relates to an in vitro method for determining whether a patient having hyperplastic polyps is at risk of developing a colonic neoplasia after resection of said hyperplastic polyps, said method comprising the step of determining the level of progastrin expression in a tissue sample of a hyperplastic polyp obtained from said patient.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: August 9, 2016
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PAUL SABATIER—TOULOUSE III, CENTRE HOSPITALIER UNIVERSITAIRE de TOULOUSE
    Inventors: Catherine Seva, Catherine Do, Audrey Ferrand, Julien Palasse, Marie-Bernadette Delisle
  • METHOD FOR PREDICTING THE RISK OF DEVELOPING A COLONIC NEOPLASIA
    Publication number: 20140186366
    Abstract: The present invention relates to an in vitro method for determining whether a patient having hyperplastic polyps is at risk of developing a colonic neoplasia after resection of said hyperplastic polyps, said method comprising the step of determining the level of progastrin expression in a tissue sample of a hyperplastic polyp obtained from said patient.
    Type: Application
    Filed: May 31, 2012
    Publication date: July 3, 2014
    Applicants: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PAUL SABATIER - TOULOUSE III
    Inventors: Catherine Seva, Catherine Do, Audrey Ferrand, Julien Palasse, Marie-Bernadette Delisle